Evidence map›Paper›PMID 33092727›Full record

ReviewJournal of the American College of Cardiology2020

Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors.

Sera Whitelaw, Lehana Thabane, Mamas A Mamas, Nosheen Reza, Khadijah Breathett, Pamela S Douglas, Harriette G C Van Spall

Abstract readReview
In one paragraph

Review in Journal of the American College of Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Underrepresentation of women in cardiovascular disease clinical Trials-What's in a Name?International journal of cardiology. Heart & vasculature · 2024
    Article
  4. Review
  5. Article
  6. Review
  7. Sex Disparities in Cardiovascular Disease.Methodist DeBakey cardiovascular journal · 2024
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Dear colleagues: enough with the men-only author panels.European heart journal supplements : journal of the European Society of Cardiology · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Why is it important for male cardiologists to enroll more women in cardiovascular trials?American heart journal plus : cardiology research and practice · 2022
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Sera WhitelawDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada. Electronic address: https://twitter.com/serawhitelaw.
Lehana ThabaneDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Mamas A MamasKeele Cardiovascular Research Group, Keele University, Stroke-on-Trent, United Kingdom. Electronic address: https://twitter.com/mmamas1973.
Nosheen RezaDivision of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: https://twitter.com/noshreza.
Khadijah BreathettDivision of Cardiovascular Medicine, Sarver Heart Center, University of Arizona, Tucson, Arizona. Electronic address: https://twitter.com/KBreathettMD.
Pamela S DouglasDuke University Clinical Research Institute, Duke University, Durham, North Carolina. Electronic address: https://twitter.com/pamelasdouglas.
Harriette G C Van SpallDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Population Health Research Institute, Hamilton, Ontario, Canada. Electronic address: Harriette.VanSpall@phri.ca.

Funding

Institutional Clinical and Translational Science AwardKL2TR001879 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI MEAGHER, EMMA ANNE · 2016 to 2025
$13.7M
Addressing Individual Provider Bias and Group Decision-Making in Selection of Advanced Heart Failure Therapies in Racial/Ethnic MinoritiesK01HL142848 · NHLBI · UNIVERSITY OF ARIZONA · PI BREATHETT, KHADIJAH · 2018 to 2021
$858k
NCATS NIH HHS KL2 TR001879NHLBI NIH HHS K01 HL142848NHLBI NIH HHS L30 HL148881
6 · The paper itself

Abstract

backgroundClinical trials change practice in cardiology, and leading them requires research training, mentorship, sponsorship, and networking. Women report challenges in obtaining these opportunities.

objectivesThe purpose of this review was to evaluate temporal trends in representation of women as authors in heart failure (HF) randomized controlled trials (RCTs) published in high-impact medical journals and explore RCT characteristics associated with women as lead authors.

methodsWe searched MEDLINE, EMBASE, and CINAHL for HF RCTs published in journals with an impact factor ≥10 between January 1, 2000, and May 7, 2019. We assessed temporal trends in the gender distribution of authors, and used multivariable logistic regression to determine characteristics associated with women as lead authors.

resultsWe identified 10,596 unique articles, of which 403 RCTs met inclusion criteria. Women represented 15.6% (95% confidence interval [CI]: 12.2% to 19.6%), 12.9% (95% CI: 9.8% to 16.6%), and 11.4% (95% CI: 8.5% to 14.9%) of lead, senior, and corresponding authors, respectively. The proportion of women authors has not changed over time. Women had lower odds of lead authorship in RCTs that were multicenter (odds ratio [OR]: 0.58; 95% CI: 0.18 to 0.96; p = 0.037), were coordinated in North America (OR: 0.21; 95% CI: 0.08 to 0.70; p = 0.011) or Europe (OR: 0.33; 95% CI: 0.09 to 0.91; p = 0.039), tested drug interventions (OR: 0.42; 95% CI: 0.16 to 0.97; p = 0.043), or had men as the senior author (OR: 0.50; 95% CI: 0.21 to 0.93; p = 0.043).

conclusionsWomen are under-represented as authors of HF RCTs, with no change in temporal trends. Women had lower odds of lead authorship in RCTs that were multicenter, were coordinated in North America or Europe, tested drug interventions, or had men as senior authors.

Indexed as

AuthorshipHeart FailureBibliometricsFemaleHumansPeriodicals as TopicPublishingRandomized Controlled Trials as Topicauthorsgenderheart failurerandomized controlled trials

Identifiers

PMID33092727
PMCPMC7713703

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.